Newsroom

2007

Koronis Pharmaceuticals Announces Issuance of U.S. Patent for KP-1461 Therapeutic in Development for Treatment of HIV (July 23, 2007)
READ MORE >>

Koronis Pharmaceuticals Raises $20 Million -- Series D to Fund Phase 2 Proof-of-Concept Trials of HIV Therapeutic (June 28, 2007)
READ MORE >>

Koronis Pharmaceuticals Begins Phase 2a Proof of Concept Study of KP-1461, a Novel, Viral Decay Acceleration™ Agent for HIV Infection (June 26, 2007)
READ MORE >>

Koronis Pharmaceuticals Receives Notice of Allowance on Patent for Novel Therapeutic KP-1461 in Development for Treatment of HIV (April 19, 2007)
READ MORE >>

Koronis Presents at the Invest Northwest CEO & Investor Forum in Seattle (March 21, 2007)

Koronis Completes Planned Enrollment in Phase 1b Clinical Study of KP-1461 in Treatment Experienced HIV Positive Patients; FDA Allows Additional Cohort of Patients to be Enrolled at Higher Dose (March 7, 2007)

Koronis Presents at BIO CEO & Investor Conference 2007 in New York (February 14, 2007)

2006

Koronis Pharmaceuticals Appoints Stephen Becker, M.D., Chief Medical Officer (October 26, 2006)
READ MORE >>

Koronis Presents Invited Talk on KP-1461 at the 2006 International Meeting of the Institute of Human Virology (November 17, 2006)

Koronis Presents at the Rodman & Renshaw Healthcare Conference 2006 at the Palace Hotel, New York, NY. Board Chairman and Interim CEO Donald Elmer Provides a Corporate Update (November 6, 2006)

Koronis Presents at the BIO Investorforum 2006 at the Palace Hotel, San Franciso, CA. Board Chairman and Interim CEO Donald Elmer Provides a Corporate Update (October 18, 2006)

Koronis Presents at the Pacific Growth Equities 2006 Life Sciences Growth Conference at the Intercontinental Mark Hopkins Hotel, San Francisco (June 12, 2006)

Koronis Pharmaceuticals Presents at the Annual Invest Northwest Investor-CEO Forum at the Bell Harbor International Conference Center, Seattle (March 22, 2006)

Koronis Pharmaceuticals Participates in Panel "Infectious Disease: Next Wave of HIV Drugs" at BIO CEO & Investor Conference (February 9, 2006)
READ MORE >>

2005

Koronis Pharmaceuticals Begins Phase 1b Clinical Trial of Novel antiviral HIV/AIDS therapeutic in HIV-Positive Patients. (October 12, 2005)  
READ MORE >>

Koronis Files an Amendment to its IND to Begin Phase 1b Clinical Trials of its antiviral Drug KP-1461 (May 27, 2005)

Koronis Announces Completion of Enrollment in Phase 1a Trial of KP-1461 (March 18, 2005)

2004

Koronis Initiates Phase 1a Clinical Trials with its Anti-HIV Drug, KP-1461 (November 30, 2004)

Koronis Receives FDA Approval to Begin Human Clinical Trials with its Anti-HIV Drug, KP-1461 (November 17, 2004)

Koronis Files an IND with FDA to Begin Human Clinical Trials with its Anti-HIV Drug, KP-1461 (August 4, 2004)

Stay Informed

To keep updated on Koronis' latest events and news releases, please go to our contact page and enter your name and email address to be added to our email news distribution list.